Fig. 1From: Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathwayPreparation for shRNA screening platform. a The cell toxicity assay of paclitaxel in variant breast cancer cell lines. b The GFP transfection efficiency of different coating conditions. c. The stability of coating plates after storing in variant conditions. d Diagram of shRNA screening procedure of breast cancer cellsBack to article page